Legal access pathways
The NSW Government is strongly committed to an evidence-based approach to the use of all medicines, including the use of cannabis-based medicines. We are working to support appropriately qualified medical practitioners to access legal, safe and effective pharmaceutical-grade cannabis medicines where they consider this to be an appropriate treatment option for their patients.
The Australian Government’s Therapeutic Goods Administration (TGA) may approve the supply of unregistered cannabis medicines under the following pathways: a Clinical Trial, the Authorised Prescriber Scheme and the Special Access Scheme.
Individual patients cannot apply to obtain approval to import and access unapproved cannabis medicines. Access can only be arranged through an Australian registered medical practitioner with appropriate qualifications and/or expertise for the medical condition requiring treatment. Approval or authorisation is granted on a case-by-case basis.
The below fact sheet details the pathways to legal access of unregistered cannabis medicines in NSW.